Advisors Asset Management, Inc. Amgen Inc Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 111,492 shares of AMGN stock, worth $32.1 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

111,492

Previous 113,817 2.04%

Holding current value

$32.1 Million

Previous $35.6 Million 1.02%

% of portfolio

0.68%

Previous 0.71%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $719,308 - $784,408	-2,325 Reduced 2.04%	111,492 $35.9 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $959,825 - $1.17 Million	-3,653 Reduced 3.11%	113,817 $35.6 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $2.99 Million - $3.6 Million	11,104 Added 10.44%	117,470 $33.4 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $3.11 Million - $3.51 Million	12,169 Added 12.92%	106,366 $30.6 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $529,032 - $625,570	-2,469 Reduced 2.55%	94,197 $20.9 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $646,888 - $788,448	-2,865 Reduced 2.88%	96,666 $23.4 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $2.28 Million - $2.9 Million	-9,952 Reduced 9.09%	99,531 $26.1 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $5.14 Million - $5.8 Million	-22,911 Reduced 17.31%	109,483 $24.7 Million
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $184,337 - $205,135	-799 Reduced 0.6%	132,394 $32.2 Million
Q1 2022 May 17, 2022	BUY	$219.27 - $242.57 $3.75 Million - $4.15 Million	17,113 Added 14.74%	133,193 $32.2 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $2.85 Million - $3.26 Million	14,318 Added 14.07%	116,080 $26.1 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $2.65 Million - $3.1 Million	12,467 Added 13.96%	101,762 $21.6 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $7.17 Million - $7.96 Million	30,713 Added 52.43%	89,295 $21.8 Million
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $1.6 Million - $1.87 Million	7,228 Added 14.07%	58,582 $14.6 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $244,942 - $291,682	1,132 Added 2.25%	51,354 $11.8 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1.15 Million - $1.28 Million	-4,915 Reduced 8.91%	50,222 $12.8 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $907,354 - $1.11 Million	-4,587 Reduced 7.68%	55,137 $13 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $1.2 Million - $1.6 Million	-6,607 Reduced 9.96%	59,724 $12.1 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $55,249 - $71,014	292 Added 0.44%	66,331 $16 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $73,474 - $88,037	-422 Reduced 0.63%	66,039 $12.8 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $602,287 - $706,016	-3,613 Reduced 5.16%	66,461 $12.2 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $697,977 - $786,772	-3,859 Reduced 5.22%	70,074 $13.3 Million
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $252,971 - $295,298	1,418 Added 1.96%	73,933 $14.4 Million
Q3 2018 Nov 15, 2018	BUY	$185.29 - $208.89 $575,696 - $649,021	3,107 Added 4.48%	72,515 $15 Million
Q2 2018 Aug 22, 2018	BUY	$166.05 - $186.51 $4.71 Million - $5.29 Million	28,349 Added 69.04%	69,408 $12.8 Million
Q2 2018 Aug 15, 2018	SELL	$166.05 - $186.51 $4.59 Million - $5.15 Million	-27,630 Reduced 40.22%	41,059 $12.8 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $219,242 - $256,212	-1,294 Reduced 1.85%	68,689 $12.6 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1.43 Million - $1.6 Million	8,467 Added 13.76%	69,983 $12.2 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $10.3 Million - $11.7 Million	61,516	61,516 $11.5 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Amgen Inc Transaction History